Methadone for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery

Sponsor
Ochsner Health System (Other)
Overall Status
Completed
CT.gov ID
NCT03778372
Collaborator
(none)
55
1
23.4
2.4

Study Details

Study Description

Brief Summary

Strabismus surgery for children is a very common procedure, with a high incidence of emergence delirium in the recovery room. Pain is often implicated in delirium. The primary aim of this study is to determine whether a single, intraoperative dose of methadone for outpatient ambulatory pediatric strabismus surgery reduces postoperative delirium.

Condition or Disease Intervention/Treatment Phase

Study Design

Study Type:
Observational
Actual Enrollment :
55 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Methadone for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery
Actual Study Start Date :
Jan 1, 2019
Actual Primary Completion Date :
Dec 13, 2020
Actual Study Completion Date :
Dec 13, 2020

Arms and Interventions

Arm Intervention/Treatment
study

pediatric patients undergoing outpatient strabismus surgery, and receiving methadone

Drug: Methadone
see desc above

control

pediatric patients undergoing outpatient strabismus surgery, and not receiving methadone

Outcome Measures

Primary Outcome Measures

  1. Pediatric Anesthesia Emergence Delirium scale scores [measured every 10 minutes in the recovery room, until patient is discharged, up to 6 hours.]

    A low total score would indicate less emergence delirium

Secondary Outcome Measures

  1. wong-baker or numeric pain scores, depending on age [measured every 10 minutes in the recovery room, until patient is discharged, up to 6 hours.]

    A low total score would indicate less pain

  2. discharge time [24 hours]

    time the patient is actually discharged from recovery room

Eligibility Criteria

Criteria

Ages Eligible for Study:
0 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ASA I/II children undergoing outpatient strabismus surgery
Exclusion Criteria:
  • anything not meeting the above

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ochsner Main Campus Jefferson Louisiana United States 70121

Sponsors and Collaborators

  • Ochsner Health System

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Khaled Dajani, Assistant Professor, Ochsner Health System
ClinicalTrials.gov Identifier:
NCT03778372
Other Study ID Numbers:
  • Pro00014855
First Posted:
Dec 19, 2018
Last Update Posted:
Jul 19, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 19, 2022